Current controversies in trichology: a European expert consensus statement.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
10
06
2021
accepted:
13
08
2021
entrez:
20
10
2021
pubmed:
21
10
2021
medline:
25
2
2023
Statut:
ppublish
Résumé
Hair disorders are one of the most common conditions within dermatology practice but, although new diagnostic tools and therapeutic options have arisen, the management of these patients still represents a major clinical challenge. This study aimed at gathering information and achieving consensus on relevant recommendations on the latest advances in alopecia, trichoscopy and hair dermocosmetics. Experts of the steering committee consulted the available evidence on trichology-related areas from the past 5 years and formulated recommendations based on the evidence and their experience. A modified two-round Delphi procedure was performed among 45 European dermatologists experts in trichology to consult their degree of agreement on twenty recommendations, using a 4-point Likert scale. Consensus was defined as >80% of participants scoring either 1 (totally agree) or 2 (agree). In the first round of the Delphi questionnaire, 75% of the recommendations reached consensus. Those that were not agreed upon were reformulated by the steering committee and voted again after an online meeting, where consensus was achieved in all recommendations. All recommendations reached consensus after the two-round Delphi questionnaire and may be useful in clinical practice for dermatologists. The participants agreed that besides this consensus, further clinical studies are needed to assess the benefits of the emerging tools and treatments and to clarify the controversies that still exist in the field, aiming at improving patients' quality of life.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3-11Subventions
Organisme : DUCRAY Laboratories Dermatologiques
Informations de copyright
© 2021 European Academy of Dermatology and Venereology.
Références
Urban J, Qi L, Zhao H, Rybak I, Rauen KA, Kiuru M. Comparison of hair manifestations in cardio-facio-cutaneous and Costello syndromes highlights the influence of the RAS pathway on hair growth. J Eur Acad Dermatol Venereol 2020; 34: 601-607.
Panchaprateep R, Lueangarun S. Efficacy and safety of oral minoxidil 5 mg once daily in the treatment of male patients with androgenetic alopecia: an open-label and global photographic assessment. Dermatol Ther (Heidelb) 2020; 10: 1345-1357.
Jimenez-Cauhe J, Saceda-Corralo D, Rodrigues-Barata R et al. Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia. J Am Acad Dermatol 2019; 81: 648-649.
Sanabria B, Vanzela TN, Miot HA, Müller RP. Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients. J Am Acad Dermatol 2021; 84: 1175-1178.
Perera E, Sinclair R. Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study. F1000Res 2017; 6: 1650.
Vano-Galvan S, Trindade de Carvalho L, Saceda-Corralo D et al. Oral minoxidil improves background hair thickness in lichen planopilaris. J Am Acad Dermatol 2021; 84: 1684-1686.
Vañó-Galván S, Pirmez R, Hermosa-Gelbard A et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol 2021; 84: 1644-1651.
Ismail FF, Meah N, Trindade de Carvalho L, Bhoyrul B, Wall D, Sinclair R. Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients. J Am Acad Dermatol 2020; 83: 1478-1479.
Fernandez-Nieto D, Saceda-Corralo D, Rodrigues-Barata R et al. Oral bicalutamide for female pattern hair loss: a pilot study. Dermatol Ther 2019; 32: e13096.
Fernandez-Nieto D, Saceda-Corralo D, Jimenez-Cauhe J et al. Bicalutamide: a potential new oral antiandrogenic drug for female pattern hair loss. J Am Acad Dermatol 2020; 83: e355-e356.
Pindado-Ortega C, Saceda-Corralo D, Moreno-Arrones Ó et al. Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice. J Am Acad Dermatol 2021; 84: 1285-1294.
Jha AK. Platelet-rich plasma for the treatment of lichen planopilaris. J Am Acad Dermatol 2018; 79: e95-e96.
Svigos K, Yin L, Shaw K et al. Use of platelet-rich plasma in lichen planopilaris and its variants: a retrospective case series demonstrating treatment tolerability without koebnerization. J Am Acad Dermatol 2020; 83: 1506-1509.
Ekelem C, Pham C, Atanaskova MN. A Systematic review of the outcome of hair transplantation in primary scarring alopecia. Skin Appendage Disord 2019; 5: 65-71.
Vañó-Galván S, Villodres E, Pigem R et al. Hair transplant in frontal fibrosing alopecia: a multicenter review of 51 patients. J Am Acad Dermatol 2019; 81: 865-866.
Cheung EJ, Sink JR, English Iii JC. Vitamin and mineral deficiencies in patients with telogen effluvium: a retrospective cross-sectional study. J Drugs Dermatol 2016; 15: 1235-1237.
Deloche C, Bastien P, Chadoutaud S et al. Low iron stores: a risk factor for excessive hair loss in non-menopausal women. Eur J Dermatol 2007; 17: 507-512.
Park SY, Na SY, Kim JH, Cho S, Lee JH. Iron plays a certain role in patterned hair loss. J Korean Med Sci 2013; 28: 934-938.
Rasheed H, Mahgoub D, Hegazy R et al. Serum ferritin and vitamin d in female hair loss: do they play a role? Skin Pharmacol Physiol 2013; 26: 101-107.
Sanke S, Samudrala S, Yadav A, Chander R, Goyal R. Study of serum vitamin D levels in men with premature androgenetic alopecia. Int J Dermatol 2020; 59: 1113-1116.
Sant'Anna Addor FA, Donato LC, Melo CSA. Comparative evaluation between two nutritional supplements in the improvement of telogen effluvium. Clin Cosmet Investig Dermatol 2018; 11: 431-436.
Conic RRZ, Piliang M, Bergfeld W, Atanaskova-Mesinkovska N. Vitamin D status in scarring and non-scarring alopecia. J Am Acad Dermatol 2018; 18: 577-584.
Dhurat R, Chitallia J, May TW et al. An open-label randomized multicenter study assessing the noninferiority of a caffeine-based topical liquid 0.2% versus minoxidil 5% solution in male androgenetic alopecia. Skin Pharmacol Physiol 2017; 30: 298-305.
Pekmezci E, Dündar C, Türkoğlu M. A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study. Acta Dermatovenerol Alp Pannonica Adriat 2018; 27: 51-57.
Lim KM, An S, Lee OK et al. Analysis of changes in microRNA expression profiles in response to the troxerutin-mediated antioxidant effect in human dermal papilla cells. Mol Med Rep 2015; 12: 2650-2660.
Gherardini J, Wegner J, Chéret J et al. Transepidermal UV radiation of scalp skin ex vivo induces hair follicle damage that is alleviated by the topical treatment with caffeine. Int J Cosmet Sci 2019; 41: 164-182.
Saoraya Lueangarun RP, Tempark T, Noppakun N. Efficacy and safety of oral minoxidil 5 mg daily during 24-week treatment in male androgenetic alopecia. J Am Acad Dermatol 2015; 72(Suppl. 1): AB113.
Pirmez R, Salas-Callo CI. Very-low-dose oral minoxidil in male androgenetic alopecia: a study with quantitative trichoscopic documentation. J Am Acad Dermatol 2020; 82: e21-e22.
Eun HC, Kwon OS, Yeon JH et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol 2010; 63: 252-258.
Moftah N, Abd-Elaziz G, Ahmed N, Hamed Y, Ghannam B, Ibrahim M. Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation. J Eur Acad Dermatol Venereol 2013; 27: 686-693.
Reguero-Del Cura L, Durán-Vian C, de Quintana-Sancho A. RF-mesotherapy with dutasteride: a future alternative treatment for androgenetic alopecia. Actas Dermosifiliogr 2020; 111: 419-420.
Saceda-Corralo D, Rodrigues-Barata AR, Vañó-Galván S, Jaén-Olasolo P. Mesotherapy with dutasteride in the treatment of androgenetic alopecia. Int J Trichology 2017; 9: 143-145.
Abdallah M, El-Zawahry KA, Besar H. Mesotherapy using dutasteride-containing solution in male pattern hair loss: a controlled pilot study. J Pan Arab Leag Dermatol 2009; 20: 137-145.
Sobhy N, Aly H, El Shafee A, El Deeb M. Evaluation of the effect of injection of dutasteride as mesotherapeutic tool in treatment of androgenetic alopecia in males. Our Dermatol Online 2013; 4: 40.
Żeberkiewicz M, Rudnicka L, Malejczyk J. Immunology of alopecia areata. Cent Eur J Immunol 2020; 45: 325-333.
Conic RZ, Tamashunas NL, Damiani G et al. Comorbidities in pediatric alopecia areata. J Eur Acad Dermatol Venereol 2020; 34: 2898-2901.
Rudnicka L, Waśkiel-Burnat A. Systemic aspects of alopecia areata Comment to the article by Lai and Sinclair. J Eur Acad Dermatol Venereol 2021; 35: e214-e215.
Shahidi-Dadras M, Bahraini N, Rajabi F, Younespour S. Patients with alopecia areata show signs of insulin resistance. Arch Dermatol Res 2019; 311: 529-533.
Wang E, Chong K, Yu M et al. Development of autoimmune hair loss disease alopecia areata is associated with cardiac dysfunction in C3H/HeJ mice. PLoS ONE 2013; 8: e62935.
Robinson G, McMichael A, Wang SQ, Lim HW. Sunscreen and frontal fibrosing alopecia: A review. J Am Acad Dermatol 2020; 82: 723-728.
Moreno-Arrones OM, Saceda-Corralo D, Rodrigues-Barata AR et al. Risk factors associated with frontal fibrosing alopecia: a multicentre case-control study. Clin Exp Dermatol 2019; 44: 404-410.
Debroy Kidambi A, Dobson K, Holmes S et al. Frontal fibrosing alopecia in men: an association with facial moisturizers and sunscreens. Br J Dermatol 2017; 177: 260-261.
Aldoori N, Dobson K, Holden CR, McDonagh AJ, Harries M, Messenger AG. Frontal fibrosing alopecia: possible association with leave-on facial skin care products and sunscreens; a questionnaire study. Br J Dermatol 2016; 175: 762-767.
Tosti A, Bergfeld WF, Christiano AM, et al. Response from the American Hair Research Society to "Sunscreen and frontal fibrosing alopecia: A review". J Am Acad Dermatol 2020; 82: 729-730.
Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci 2020; 21: 7794.
Alessandrini A, Brattoli G, Piraccini BM, Di Altobrando A, Starace M. The Role of Trichoscopy in Keratosis Follicularis Spinulosa Decalvans: Case Report and Review of the Literature. Skin Appendage Disord 2021; 7: 29-35.
Waśkiel-Burnat A, Rakowska A, Sikora M, Ciechanowicz P, Olszewska M, Rudnicka L. Trichoscopy of tinea capitis: a systematic review. Dermatol Ther (Heidelb) 2020; 10: 43-52.
Saceda-Corralo D, Moreno-Arrones OM, Rodrigues-Barata R et al. Trichoscopy activity scale for folliculitis decalvans. J Eur Acad Dermatol Venereol 2020; 34: e55-e57.
Chanprapaph K, Udompanich S, Visessiri Y, Ngamjanyaporn P, Suchonwanit P. Nonscarring alopecia in systemic lupus erythematosus: A cross-sectional study with trichoscopic, histopathologic, and immunopathologic analyses. J Am Acad Dermatol 2019; 81: 1319-1329.
Alessandrini A, Starace M, Bruni F et al. Alopecia Areata incognita and diffuse alopecia areata: clinical, trichoscopic, histopathological, and therapeutic features of a 5-year study. Dermatol Pract Concept 2019; 9: 272-277.
Starace M, Alessandrini A, Brandi N, Piraccini BM. Preliminary results of the use of scalp microneedling in different types of alopecia. J Cosmet Dermatol 2020; 19: 646-650.
Griggs J, Trüeb RM, Gavazzoni Dias MFR, Hordinsky M, Tosti A. Fibrosing alopecia in a pattern distribution. J Am Acad Dermatol 2020. doi: 10.1016/j.jaad.2019.12.056. Online ahead of print.
Du X, Li Y, Zhu Q et al. Focal and diffuse fibrosing alopecias: Classical lichen planopilaris, frontal fibrosing alopecia, fibrosing alopecia with a pattern distribution, cicatricial pattern hair loss, and lichen planopilaris diffuse pattern. JAAD Case Rep 2020; 6: 403-410.
Ekelem C, Juhasz M, Khera P, Mesinkovska NA. Utility of naltrexone treatment for chronic inflammatory dermatologic conditions: a systematic review. JAMA Dermatol 2019; 155: 229-236.
Strazzulla LC, Avila L, Lo Sicco K, Shapiro J. Novel treatment using low-dose naltrexone for lichen planopilaris. J Drugs Dermatol 2017; 16(11): 1140-1142.
Lajevardi V, Salarvand F, Ghiasi M, Nasimi M, Taraz M. The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris: a randomized controlled clinical trial. J Dermatolog Treat 2020; doi: 10.1080/09546634.2020.1774488. Online ahead of print.
Wang X, Zhang Y, Peng Y et al. Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4. Br J Pharmacol 2016; 173: 856-869.
Van TN, Thi NH, Van TH et al. Efficacy of oral itraconazole in the treatment of seborrheic dermatitis in vietnamese adults patients. Open Access Maced J Med Sci 2019; 7: 224-226.
Park HK, Ha MH, Park SG, Kim MN, Kim BJ, Kim W. Characterization of the fungal microbiota (mycobiome) in healthy and dandruff-afflicted human scalps. PLoS ONE 2012; 7: e32847.
Moreno-Arrones OM, Serrano-Villar S, Perez-Brocal V et al. Analysis of the gut microbiota in alopecia areata: identification of bacterial biomarkers. J Eur Acad Dermatol Venereol 2020; 34: 400-405.
Migacz-Gruszka K, Branicki W, Obtulowicz A, Pirowska M, Gruszka K, Wojas-Pelc A. What's new in the pathophysiology of alopecia areata? The possible contribution of skin and gut microbiome in the pathogenesis of alopecia - big opportunities, big challenges, and novel perspectives. Int J Trichology 2019; 11: 185-188.
Lewis DJ, Chan WH, Hinojosa T, Hsu S, Feldman SR. Mechanisms of microbial pathogenesis and the role of the skin microbiome in psoriasis: A review. Clin Dermatol 2019; 37: 160-166.
Tett A, Pasolli E, Farina S et al. Unexplored diversity and strain-level structure of the skin microbiome associated with psoriasis. NPJ biofilms and microbiomes 2017; 3: 14.
Shin W, Rosin NL, Sparks H et al. Dysfunction of hair follicle mesenchymal progenitors contributes to age-associated hair loss. Dev Cell 2020; 53: 185-98.e7.
Matsumura H, Mohri Y, Binh NT et al. Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis. Science 2016; 351(6273): aad4395.
Cao W, Li L, Kajiura S et al. Aging hair follicles rejuvenated by transplantation to a young subcutaneous environment. Cell Cycle 2016; 15: 1093-1098.
Williams R, Westgate GE, Pawlus AD, Sikkink SK, Thornton MJ. Age-related changes in female scalp dermal sheath and dermal fibroblasts: how the hair follicle environment impacts hair aging. J Invest Dermatol 2021; 141: 1041-1051.
Takahashi T, Mamada A, Breakspear S, Itou T, Tanji N. Age-dependent changes in damage processes of hair cuticle. J Cosmet Dermatol 2015; 14: 2-8.
Madaan A, Verma R, Singh AT, Jaggi M. Review of hair follicle dermal papilla cells as in vitro screening model for hair growth. Int J Cosmet Sci 2018; 40: 429-450.
Philpott MP. Culture of the human pilosebaceous unit, hair follicle and sebaceous gland. Exp Dermatol 2018; 27: 571-577.
Castro AR, Logarinho E. Tissue engineering strategies for human hair follicle regeneration: how far from a hairy goal? Stem Cells Transl Med 2020; 9: 342-350.
Abaci HE, Coffman A, Doucet Y et al. Tissue engineering of human hair follicles using a biomimetic developmental approach. Nat Commun 2018; 9: 5301.
Lee J, Rabbani CC, Gao H et al. Hair-bearing human skin generated entirely from pluripotent stem cells. Nature 2020; 582: 399-404.
Bassino E, Antoniotti S, Gasparri F, Munaron L. Effects of flavonoid derivatives on human microvascular endothelial cells. Nat Prod Res 2016; 30: 2831-2834.
Völker JM, Koch N, Becker M, Klenk A. Caffeine and its pharmacological benefits in the management of androgenetic alopecia: a review. Skin Pharmacol Physiol 2020; 33: 93-109.
Daniels G, Akram S, Westgate GE, Tamburic S. Can plant-derived phytochemicals provide symptom relief for hair loss? A critical review. Int J Cosmet Sci 2019; 41: 332-345.
Kil MS, Kim CW, Kim SS. Analysis of serum zinc and copper concentrations in hair loss. Ann Dermatol 2013; 25: 405-409.
Abdel Aziz AM, Sh Hamed S, Gaballah MA. Possible relationship between chronic telogen effluvium and changes in lead, cadmium, zinc, and iron total blood levels in females: a case-control study. Int J Trichology 2015; 7: 100-106.
Deo K, Sharma YK, Wadhokar M, Tyagi N. Clinicoepidemiological observational study of acquired alopecias in females correlating with anemia and thyroid function. Dermatol Res Pract 2016; 2016: 1-5.